Sickle cell disease Trials in Paris, France
Conditions / Sickle cell disease / Paris, France
Sickle cell disease is a medical condition with active clinical research programs worldwide.
43 total trials for this combination
Showing top 10 of 43 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT06609226 | A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia | RECRUITING | PHASE3 |
| NCT06612268 | A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease | RECRUITING | — |
| NCT05031780 | A Study Evaluating the Efficacy and Safety of Mitapivat (AG-348) in Participants With Sickle Cell Disease (RISE UP) | ACTIVE_NOT_RECRUITING | — |
| NCT06612268 | A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease | RECRUITING | — |
| NCT03573882 | Study to Assess the Effect of Long-term Treatment With Voxelotor in Participants Who Have Completed Treatment in Study GBT440-031 | TERMINATED | PHASE3 |
| NCT04624659 | A Study of Etavopivat in Adults and Adolescents With Sickle Cell Disease (HIBISCUS) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT06975865 | The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease | RECRUITING | — |
| NCT03036813 | Study to Evaluate the Effect of Voxelotor Administered Orally to Patients With Sickle Cell Disease (GBT_HOPE) | COMPLETED | PHASE3 |
| NCT06147414 | Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders | RECRUITING | — |
| NCT01090323 | Evaluation of the Safety, Tolerability, Pharmacokinetics (PK) and Effects on Liver Iron Concentration of ICL670 Relative to Deferoxamine(DFO). | COMPLETED | PHASE2 |